Literature DB >> 7685274

p53-catalyzed annealing of complementary single-stranded nucleic acids.

P Oberosler1, P Hloch, U Ramsperger, H Stahl.   

Abstract

p53 has been reported to inhibit the DNA helicase intrinsic to simian virus 40 large tumor antigen (T antigen). We found that inhibition is not restricted to T antigen, but also affects several other DNA and RNA helicases. Complexing of the helicases by the p53 protein as a possible inactivation mechanism could be excluded. Instead, the anti-helicase activity can be explained by our finding that p53 binds with high affinity to single-stranded nucleic acids and has a strong DNA.DNA and RNA.RNA annealing activity. We could also show that p53 is able to alter the secondary structure of RNA and/or to influence dynamic RNA-RNA interactions. These results, and the fact that the affinity of p53 to RNA is about one order of magnitude higher than to single-stranded DNA, imply an RNA-specific function of p53 in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7685274      PMCID: PMC413469          DOI: 10.1002/j.1460-2075.1993.tb05893.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  66 in total

1.  Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.

Authors:  L R Livingstone; A White; J Sprouse; E Livanos; T Jacks; T D Tlsty
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

2.  T antigen is bound to a host protein in SV40-transformed cells.

Authors:  D P Lane; L V Crawford
Journal:  Nature       Date:  1979-03-15       Impact factor: 49.962

3.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

4.  Oncogenic forms of p53 inhibit p53-regulated gene expression.

Authors:  S E Kern; J A Pietenpol; S Thiagalingam; A Seymour; K W Kinzler; B Vogelstein
Journal:  Science       Date:  1992-05-08       Impact factor: 47.728

5.  Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells.

Authors:  D I Linzer; A J Levine
Journal:  Cell       Date:  1979-05       Impact factor: 41.582

6.  Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.

Authors:  Y Yin; M A Tainsky; F Z Bischoff; L C Strong; G M Wahl
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

7.  p53 is covalently linked to 5.8S rRNA.

Authors:  B M Fontoura; E A Sorokina; E David; R B Carroll
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

8.  Specific and complex interactions of murine p53 with DNA.

Authors:  S N Weissker; B F Müller; A Homfeld; W Deppert
Journal:  Oncogene       Date:  1992-10       Impact factor: 9.867

9.  Monoclonal antibodies against simian virus 40 T antigens: evidence for distinct sublcasses of large T antigen and for similarities among nonviral T antigens.

Authors:  E G Gurney; R O Harrison; J Fenno
Journal:  J Virol       Date:  1980-06       Impact factor: 5.103

10.  Enhanced binding of a 95 kDa protein to p53 in cells undergoing p53-mediated growth arrest.

Authors:  Y Barak; M Oren
Journal:  EMBO J       Date:  1992-06       Impact factor: 11.598

View more
  67 in total

1.  An ATP/ADP-dependent molecular switch regulates the stability of p53-DNA complexes.

Authors:  A L Okorokov; J Milner
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  AP-1 repressor protein JDP-2: inhibition of UV-mediated apoptosis through p53 down-regulation.

Authors:  F Piu; A Aronheim; S Katz; M Karin
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

3.  Structure and expression of the human p68 RNA helicase gene.

Authors:  O G Rössler; P Hloch; N Schütz; T Weitzenegger; H Stahl
Journal:  Nucleic Acids Res       Date:  2000-02-15       Impact factor: 16.971

4.  Protein kinase CK2-dependent regulation of p53 function: evidence that the phosphorylation status of the serine 386 (CK2) site of p53 is constitutive and stable.

Authors:  L McKendrick; D Milne; D Meek
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

5.  Different regulation of the p53 core domain activities 3'-to-5' exonuclease and sequence-specific DNA binding.

Authors:  F Janus; N Albrechtsen; U Knippschild; L Wiesmüller; F Grosse; W Deppert
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

6.  Rearrangement of structured RNA via branch migration structures catalysed by the highly related DEAD-box proteins p68 and p72.

Authors:  O G Rössler; A Straka; H Stahl
Journal:  Nucleic Acids Res       Date:  2001-05-15       Impact factor: 16.971

7.  Replication of damaged DNA in vitro is blocked by p53.

Authors:  Jianmin Zhou; Carol Prives
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

8.  Activities and response to DNA damage of latent and active sequence-specific DNA binding forms of mouse p53.

Authors:  Y Wu; H Huang; Z Miner; M Kulesz-Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

9.  Recognition of RNA by the p53 tumor suppressor protein in the yeast three-hybrid system.

Authors:  Kasandra J-L Riley; Laura A Cassiday; Akash Kumar; L James Maher
Journal:  RNA       Date:  2006-04       Impact factor: 4.942

10.  Species- and tissue-specific expression of the C-terminal alternatively spliced form of the tumor suppressor p53.

Authors:  K Will; G Warnecke; S Bergmann; W Deppert
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.